Antisense modulation of PDK-1 expression

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 6, 435 3, 435 911, 435325, 435375, 536 231, 536 243, 536 2431, 536 245, A61K 4800, C07H 2104, C12Q 168, C12N 1585

Patent

active

061242721

ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of PDK-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PDK-1. Methods of using these compounds for modulation of PDK-1 expression and for treatment of diseases associated with expression of PDK-1 are provided.

REFERENCES:
patent: 6028173 (2000-02-01), Landes et al.
patent: 6030806 (2000-02-01), Landes et al.
Andrea D. Branch, A good antisense molecule is hard to find, TIBS, 47-48, Feb. 1998.
Trisha Gura, Antisense Has Growing Pains, Science, pp. 575-577, Oct. 1995.
Stanley Crooke, Antisense Research and Applications, Chapter 1, Basic Principles of Antisense Therapeutics, Springer-Verlag Press, Berlin, Heidelberg, New York, p. 3, Jul. 1998.
Uhlmann et al. Antisense Oligonucleotides: A New Therapeutic Principle. Chemical Reviews, vol. 90, No. 4., pp. 545-546, Jun. 1990.
Alessi et al., Mechanism of activation and function of protein kinase B, Curr. Opin. Genet. Dev., 1998, 8:55-62.
Alessi et al., 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase, Curr. Biol., 1997, 7:776-789.
Alessi et al., Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha, Curr. Biol., 1997, 7:261-269.
Anderson et al., Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B, Curr. Biol., 1998, 8:684-691.
Cohen et al., PDK1, one of the missing links in insulin signal transduction?, FEBS Lett., 1997, 410:3-10.
Downward, Mechanisms and consequences of activation of protein kinase B/Akt, Curr. Opin. Cell Biol., 1998, 10:262-267.
Le Good et al., Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1, Science, 1998, 281:2042-2045.
Staal, Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma, Proc. Natl. Acad. Sci. U S A, 1987, 84:5034-5037.
Staal et al., The AKT1 proto-oncogene maps to human chromosome 14, band q32, Genomics, 1988, 2:96-98.
Stokoe et al., Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B, Science, 1997, 277:567-570.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antisense modulation of PDK-1 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of PDK-1 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of PDK-1 expression will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2100286

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.